0102030405
CAS No 188416-35-5 (2R,3S/2S,3R)-3-(4-CHLORO-5-FLUOROPYRIMIDIN-6-YL)-2-(2,4-DIFLUOROPHENYL)-1-(1H-1,2,4-TRIAZOL-1-YL)BUTAN-2-OL Pharmaceutical Intermediates
02
Product detail
Product detail
(2R,3S/2S,3R)-3-(4-chloro-5-fluoropyrimidin-6-yl)-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol is a complex compound with unique molecular structure and properties. The compound has chiral centers, which contribute to its efficacy in various pharmaceutical applications. The presence of fluorine and chlorine atoms enhances its biological activity and stability, making it a valuable asset in pharmaceutical formulations.
- Molecular formula:C16H13ClF3N5O
- Molecular weight: 383.76 g/mol
- Appearance: white to off-white Solid
- Solubility: Soluble in organic solvents; slightly soluble in water
- Melting Point: Specific melting point data available upon request
02
product detail
|
CAS No. |
40856-44-8 |
|
EINECS |
609-874-3 |
|
Formula |
C9H11NO2 |
|
Molecular Weight |
165.19 |
|
Appearance |
White to Off-White solid |
|
Purity |
≥98% |
|
Type |
Pharmaceutical Intermediates |
1. High Purity: Our products undergo a rigorous purification process to ensure high purity levels, which is critical for pharmaceutical applications.
2. Multiple Applications: This compound is suitable for a variety of pharmaceutical formulations, including but not limited to antiviral and antifungal agents.
3. Enhanced stability: The addition of halogenated groups helps improve the stability of the compound, ensuring a longer shelf life and consistent performance of the formulation.
4. Chirality: The chiral properties of this compound give it targeted therapeutic effects, making it an important ingredient in the development of enantiomerically pure drugs.
(2R,3S/2S,3R)-3-(4-chloro-5-fluoropyrimidin-6-yl)-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol is a cutting-edge pharmaceutical compound that plays a key role in modern drug development. The compound has a unique chemical structure that meets the demanding needs of the pharmaceutical industry.
The compound is designed by combining a pyrimidine ring, known for its biological activity, with a triazole moiety that enhances its pharmacological properties. The difluorophenyl group further enhances its efficacy, making it a top choice for various therapeutic applications.
In the pharmaceutical industry, the need for high-quality raw materials is paramount. Our integrated manufacturing and trading facility is committed to providing products that meet the highest quality and safety standards. We use state-of-the-art manufacturing processes and adhere to strict regulatory guidelines to ensure that our products are not only effective but also safe for use in pharmaceutical formulations.
Our commitment to quality is matched only by our dedication to customer service. We understand the importance of timely delivery and competitive pricing in the pharmaceutical industry. By choosing our (2R,3S/2S,3R)-3-(4-chloro-5-fluoropyrimidin-6-yl)-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol, you will be working with a reliable supplier that prioritizes your needs.
In summary, (2R,3S/2S,3R)-3-(4-chloro-5-fluoropyrimidin-6-yl)-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol is an essential compound for pharmaceutical applications with high purity, stability and versatility. Trust our integrated facility to meet your pharmaceutical needs and experience the difference in quality and service. Contact us today to learn more about our products and how we can support your pharmaceutical business.